MAPT and Cognitive impairment: This result suggests that plasma and PET imaging T biomarkers may convey information that is at least in part not overlapping, with plasma p-tau181 concentrations being more closely related to Aβ pathology and tau PET imaging findings being mainly a reflection of the cognitive impairment severity [46].